RCGP Curriculum - 15.8 Respiratory Problems
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
The findings suggest that giving antibiotics to children early in life might make them more susceptible to asthma by reducing levels of H pylori in the body.
Previous research has suggested that the cagA strain of H pylori can protect against gastro-oesophageal reflux disease (GORD) and could, therefore, protect against GORD-related asthma.
For the latest study, the link between H pylori and asthma was assessed in 7,663 adult asthmatics.
Each participant answered a questionnaire on medical history of asthma and allergy symptoms.
They were then tested for antibodies for H pylori and the cagA protein in their blood.
A sub-group of 2,385 participants also underwent skin testing for six asthma allergens, including ragweed and rye grass. The results were correlated with participants' H pylori status.
Those with the cagA strain of H pylori were found to be 20 per cent less likely to have ever had asthma compared with participants without H pylori.
This association seemed dependant on age. Those with the virulent cagA strain were 40 per cent less likely to have had asthma before the age of 15.
What do you think? Comment below or email us at healthcare.republic@haymarket.com
Quick search - use * for an abbreviated search, eg nico*
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more
This section of our curriculum guide refers to statement 13, Care of People with Mental Health Probl... Read more
Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more
Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more
A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more
Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more
Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more
Comments
Only registered users may comment. Log in now or register for a free account.